´ëÇÑ°£¾ÏÇÐȸ Á¦18Â÷ Á¤±âÇмú´ëȸ-Liver Cancer without Borders : 2024-04-05
±³À°ÀÏÀÚ : 2024-04-05
±³À°Àå¼Ò : ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room1, Room2
±³À°ÁÖÁ¦ : ´ëÇÑ°£¾ÏÇÐȸ Á¦18Â÷ Á¤±âÇмú´ëȸ-Liver Cancer without Borders
ÁÖÃÖ±â°ü : ´ëÇÑ°£¾ÏÇÐȸ
´ã´çÀÚ : ¿ÀÀ±Àç ´ë¸®
¿¬¶ôó : 02-373-1005
À̸ÞÀÏ : klca@hbni.co.kr
±³À°Á¾·ù : ³»°ú, ¿Ü°ú, ¿µ»óÀÇÇаú, ¹æ»ç¼±Á¾¾çÇаú, º´¸®°ú
Âü¼®¿¹»óÀÎ : 400¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 10 ½Ã°£ 30ºÐ
¼¼ºÎ¼ö°·á : 60,000¿ø
ºñ°í -»çÀüµî·Ï: Æò»ý,Á¤È¸¿ø 4¸¸¿ø / ºñȸ¿ø 5¸¸¿ø / ÀüÀÓÀÇ,Àü°øÀÇ,±ºÀÇ°ü,°£È£»ç 2¸¸¿ø-ÇöÀåµî·Ï: Æò»ý,Á¤È¸¿ø 5¸¸¿ø / ºñȸ¿ø 6¸¸¿ø / ÀüÀÓÀÇ,Àü°øÀÇ,±ºÀÇ°ü,°£È£»ç 3¸¸¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 04¿ù 05ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room1 08:45~08:55 ÀÚÀ¯ ¿¬Á¦ 1 Diagnostic Biomarker Á¶ÀºÁÖ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 04¿ù 05ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room1 08:55~09:05 ÀÚÀ¯ ¿¬Á¦ 2 Predictive Surgery °¿ìÇü(¿ï»êÀÇ´ë)
±³À°½Ã°£ 04¿ù 05ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room1 09:05~09:15 ÀÚÀ¯ ¿¬Á¦ 3 Intervention and Ablation Â÷µ¿ÀÍ(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 04¿ù 05ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room1 09:15~09:25 ÀÚÀ¯ ¿¬Á¦ 4 Locoregional vs. Systemic Therapy Á¶À¯¸®(±¹¸³¾Ï¼¾ÅÍ)
±³À°½Ã°£ 04¿ù 05ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room1 09:25~09:35 ÀÚÀ¯ ¿¬Á¦ 5 Molecular- and Radio-Pathology Àü¿µ½Ä(KIST)
±³À°½Ã°£ 04¿ù 05ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room1 09:35~09:45 ÀÚÀ¯ ¿¬Á¦ 6 Radiotherapy À¯Á¤ÀÏ(¼º±Õ°üÀÇ´ë)
ÈÞ½Ä 04¿ù 05ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room1 09:45~10:00 Coffee Break .(.)
±³À°½Ã°£ 04¿ù 05ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room1 10:00~10:30 Genetic Insights for HCC Risk Stratification in Cirrhosis Jessica Zucman-Rossi(ILCA)
±³À°½Ã°£ 04¿ù 05ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room1 10:30~10:50 How to Evaluate Treatment Response of HCC Post-Systemic Therapy Jeong Min Lee(KLCA)
±³À°½Ã°£ 04¿ù 05ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room1 10:50~11:10 The Evolving Therapeutic Landscape in HCC: A 10-Year Perspective Tim Meyer(ILCA)
±³À°½Ã°£ 04¿ù 05ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room1 11:10~11:30 Multimodal and Combination Therapy for Advanced HCC Jeong Won Jang(KLCA)
±³À°½Ã°£ 04¿ù 05ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room1 11:30~11:50 Combination Immunotherapy for Intrahepatic Cholangiocarcinoma Lorenza Rimassa(ILCA)
ÈÞ½Ä 04¿ù 05ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room1 11:50~12:45 Lunch Break .(.)
±³À°½Ã°£ 04¿ù 05ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room1 12:45~13:25 2024 KLCA Practical Guidance of RFA: Expert Consensus À̵¿È£(´ëÇÑ°£¾ÏÇÐȸ ¿¬±¸ÀÌ»ç)
±³À°½Ã°£ 04¿ù 05ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room1 13:25~13:55 Advanced Surgical Techniques and Innovations for Living Donors and Recipients ¼°æ¼®(¼¿ïÀÇ´ë)
ÈÞ½Ä 04¿ù 05ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room1 13:55~14:05 Coffee Break .(.)
±³À°½Ã°£ 04¿ù 05ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room1 14:05~14:20 Novel Energies and Powers for Ablation in HCC ±è¼Ò¿¬(¿ï»êÀÇ´ë)
±³À°½Ã°£ 04¿ù 05ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room1 14:20~14:35 Technical Challenges and Opportunities in Interventional Therapies for HCC ÃÖÁø¿ì(¼¿ïÀÇ´ë)
±³À°½Ã°£ 04¿ù 05ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room1 14:35~14:50 Exploring the Potential of Carbon-Ion Radiation Therapy (CIRT) ÀÌÀÍÀç(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 04¿ù 05ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room1 14:50~15:05 Beyond Traditional Boundaries: Robotic Surgery ±è°ü¿ì(µ¿¾ÆÀÇ´ë)
±³À°½Ã°£ 04¿ù 05ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room1 15:05~15:20 Recent Advances and Future Directions in Immune-Based Therapies for HCC ÀÌÀ±ºó(¼¿ïÀÇ´ë)
±âŸ 04¿ù 05ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room1 15:20~16:20 Oral Poster Presentation .(.)
±³À°½Ã°£ 04¿ù 05ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room1 16:20~16:30 ÀÚÀ¯ ¿¬Á¦ 7 Challenge of HCC with or without Driver Molecules/Genes ¾ÈÁöÇö(ÇѾçÀÇ´ë)
±³À°½Ã°£ 04¿ù 05ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room1 16:30~16:40 ÀÚÀ¯ ¿¬Á¦ 8 Biomarkers-Guided Systemic Therapies for ICC Á¶Àη¡(¼¿ïÀÇ´ë)
±³À°½Ã°£ 04¿ù 05ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room1 16:40~16:55 Case Studies - Molecular Liver Cancer Conclave ÇÑÁö¿ø(°¡Å縯ÀÇ´ë)
Åä·Ð 04¿ù 05ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room1 16:55~17:20 Panel and Floor Discussion ±èÁöÈÆ,ÁÖµ¿Áø,À̹οì,Çöµ¿È£,À±»ó¹Î,±èÇý·É(°í·ÁÀÇ´ë, ¿¬¼¼ÀÇ´ë, ¼º±Õ°üÀÇ´ë, ¿ï»êÀÇ´ë, ¼¿ïÀÇ´ë)
±³À°½Ã°£ 04¿ù 05ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room2 08:45~09:00 °£¾ÏÀûÁ¤¼º Æò°¡-½Ã¼ú¿µ¿ªÁöÇ¥ °³¹ß¿¬±¸ º¸°í ¾çÇö(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 04¿ù 05ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room2 09:00~09:15 ÀÓ»óÇöÀå¿¡¼ °£¾Ï Àü½ÅÇ×¾ÏÁ¦ »ç¿ë À̽´ À±¾ÆÀϸ°(ÇѾçÀÇ´ë)
±³À°½Ã°£ 04¿ù 05ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room2 09:15~09:30 °£Áúȯ¿¡¼ ÁßÁõÁúȯ »êÁ¤Æ¯·Ê Á¦µµ ¼Ò°³ ±èÁøÇö(±¹¹Î°Ç°º¸Çè°ø´Ü)
Åä·Ð 04¿ù 05ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room2 09:30~09:45 ÆгΠÅäÀÇ ±èÇüÁØ,ÀÌÇö¿õ,¾çÇö,À±¾ÆÀϸ°,±èÁøÇö(Áß¾ÓÀÇ´ë,¿¬¼¼ÀÇ´ë,°¡Å縯ÀÇ´ë,ÇѾçÀÇ´ë,±¹¹Î°Ç°º¸Çè°ø´Ü)
±³À°½Ã°£ 04¿ù 05ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room2 14:05~14:20 Precision Imaging Techniques for Early Detection of Liver Cancer ÁÖÀÌÁø(¼¿ïÀÇ´ë)
±³À°½Ã°£ 04¿ù 05ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room2 14:20~14:40 Biomarker Breakthroughs: For Liver Cancer Diagnosis and Prognosis ÀÌ¿µ¼±(°í·ÁÀÇ´ë)
±³À°½Ã°£ 04¿ù 05ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room2 14:40~15:00 Understanding Pathologic Differential Diagnosis of Liver Cancer ³²ÁöÇØ(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 04¿ù 05ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room2 15:00~15:20 Optimizing Pre- and Post-Treatment Evaluation in Liver Cancer Á¶¿µÀ±(Áß¾ÓÀÇ´ë)
±³À°½Ã°£ 04¿ù 05ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room2 15:20~15:35 °£¾Ï ½Ã¼ú ¹× Ç×¾Ï Ä¡·áÀü ±³À° ·ù´ã(¼øõÇâÀÇ´ë)
±³À°½Ã°£ 04¿ù 05ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room2 15:35~15:50 °£¾Ï Ä¡·á (¼ö¼ú/½Ã¼ú/¹æ»ç¼±Ä¡·á) ȯÀÚÀÇ °£È£°ü¸® Á¤Çϸ²(»ï¼º¼¿ïº´¿ø)
±³À°½Ã°£ 04¿ù 05ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room2 15:50~16:05 Ç×¾Ï Ä¡·á ȯÀÚÀÇ °£È£°ü¸® Á¤ÀÇÁ¤(¼¼ºê¶õ½ºº´¿ø)
±³À°½Ã°£ 04¿ù 05ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room2 16:05~16:20 °£¾ÏȯÀÚÀÇ Á¤¼Àû ÁöÁö °¿ø¼·(°æÈñÀÇ´ë)
±³À°½Ã°£ 04¿ù 05ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room2 16:20~16:35 Navigating Optimal Transarterial Treatments for Liver Cancer ±Ç·Á¹Î(ÇѸ²ÀÇ´ë)
±³À°½Ã°£ 04¿ù 05ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room2 16:35~16:50 Practical Recommendation for Local Ablation of Liver Cancer °Å¿í(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 04¿ù 05ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room2 16:50~17:05 Surgical Strategies in Liver Cancer: A Comprehensive Approach À̽Âȯ(°æÈñÀÇ´ë)
±³À°½Ã°£ 04¿ù 05ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room2 17:05~17:20 Immunotherapy in Liver Cancer and Upcoming Challenges À¯Á¤ÁÖ(¼øõÇâÀÇ´ë)